Companion Diagnostics for Precision Medicine in Oncology
Spark Molecular Diagnostics focuses on mutant detection for oncology precision medicine. Using state-of-the-art technology, we provide services that are driven by results.
Our mission is to make molecular testing convenient and affordable, while providing direct access to testing, anywhere and anytime.
Detecting cancer mutation copies at the the lowest sensitivity is now possible.
Our leadership team bring years of experience to bear on the greatest challenge of our time. OneSpark’s 1 copy detection is revolutionary.
Superior to ddPCR and NGS
OneSpark provides an easy workflow, quick turnaround time, unbeaten sensitivity, and unambigious result all at a low cost.
“As a cancer specialist, we are always looking for new, revolutionary technology, and I think OneSpark is one of them.”
— Huan Giap
Chief Medical Officer at Advanced Radiation Technologies
Let’s keep in contact to advance the development of cancer technologies.
Sign up to be the first to know about our events, interesting developments, and more.